RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Somagenetix

Somagenetix

Ex-vivo gene therapy for phagocyte disorders.

Latest funding

Series A ·

Amount not disclosed in a source on record.

Funding history ↓
Website: somagenetix.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Pharmaceutical.
Stage: Series A.
Based in: Zurich, Switzerland.
Last round: Oct 9, 2024 · 768 days ago.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredOct 4, 2018 (8 years old)
About Somagenetix

Somagenetix develops lentiviral HSC programs, starting with CGD—advancing safe, durable, one-time treatments.

Funding rounds

DateRoundAmountLeadSource
Series Aundisclosed—fundraisingfox.com

Timeline

  1. Website created

Founders and team

Investors

Companies like Somagenetix

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/somagenetix (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy